About IDD - One of the fastest growing drug detection facilities in the South

 

First Picture from left: Ed Lepre, C-SAPA with K-9 Chester. Second Picture: The IDD team: (Front row from left to right) P.J. Chighizola; Harriet Battiste; Robyn Minchey; Tiffany Sanchez; Kim Lager; Marcella Lepre-Joyce; and, Collin Eskine; (Back row from left to right) Mike Fonti; Mike Prestenback; Scott VanderMeer; Ed Lepre C-SAPA, president; Eddie Greer; Adam Condrey; and Jerry Lepre. (Not pictured) Jon Cimo; Candace Poche’; and, Heather Lepre-Prestenback.

 

About IDD

Founded in 1997, International Drug Detection, LLC is one of the fastest growing drug detection facilities in the South. IDD and its staff of over 20 certified collectors/investigators are committed to a high standard of professionalism and excellence in ensuring a safe and drug free work place for its clients.

IDD, a Third-Party Administrator (TPA) which specializes in administering federally mandated drug testing programs, offers a diversified portfolio of services that ensure confidentiality, accuracy and legal defensibility.

Services include:

 

  • DOT and Non-DOT drug Screening
  • DOT and Non-DOT Alcohol testing
  • Medical Review Officer (MRO) services
  • Record keeping and statistical analysis
  • Random Selection
  • Development and administration of DOT and Non-Dot Drug and Alcohol Policies and Procedures to ensure compliance with federal and state guidelines
  • Drug prevention and detection training programs and booklets
  • K-9 Searches for contraband
  • DNA Testing
  • Finger Printing
  • Background Checks
IDD utilizes laboratory facilities that are certified by the Substance Abuse and Mental Health Services Administration (SAMHSA) to conduct federally mandated drug testing. The IDD team successfully serves a range of clients from small and mid-size businesses to Fortune 500 companies. Assignments have taken the IDD team to several states in the USA and even abroad.

IDD combines the strength of integrity with the power of innovation.

FEATURED SERVICES

 

Federal DOT mandates that only the following five drugs be tested for: amphetamines, cocaine, cannabinoids, opiates, and phencyclidine. Additional drugs beyond these five are considered non-DOT drug panels and must be tested separately. For clients that are not federally mandated they can choose what drugs they want for the testing panel and how many.